Watch CBS News

Cambridge-Based Moderna Ships Potential Coronavirus Vaccine For Testing

BOSTON (CBS/AP) - The drug maker Moderna has shipped a potential coronavirus vaccine for humans to government researchers for testing.

Shares of the biotech company soared early Tuesday, a day after the company said it sent vials to the National Institute of Allergy and Infectious Diseases for early-stage testing in the United States.

Moderna Therapeutics coronavirus vaccine
Moderna Therapeutics lab in Norwood. (Image credit: CBS News)

More than 80,000 people have been infected globally from the viral outbreak that began late last year in China. A total of 35 cases have been reported in the United States, including one in Massachusetts.

Read: CDC On Coronavirus

More than 2,600 people have died from the virus in mainland China, including one U.S. citizen.

Read: Why Coronavirus Is Dangerous

Shares of Moderna Inc., based in Cambridge, Massachusetts, jumped nearly 16% in premarket trading.

The stock started trading in late 2018 and set an all-time high price of $29.79 last April, according to FactSet.

(© Copyright 2020 CBS Broadcasting Inc. All Rights Reserved. The Associated Press contributed to this report.)

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.